2020

In 2020

Lu Xianping, the Chairman of Chipscreen Biosciences, was honored with the "Mayor's Award" of the Shenzhen Science and Technology Award 2018.

2019

In 2019

Chipscreen Biosciences was awarded the honorable title of "Emerging Pharmaceutical Enterprise of the Year" at the 2019 Listed Companies Annual Meeting and CSR Summit of the Guangdong-Hong Kong-Macao Greater Bay Area.

In 2019

Chidamide was honored with the "Excellent Product Award" at the 21st China Hi-Tech Fair.

In 2019

Chipscreen Biosciences was awarded the honorable title of "Outstanding Pharmaceutical Enterprise on the 70th Anniversary of the Founding of the People's Republic of China".

In 2019

Chipscreen Biosciences was awarded the honorable title of "Top 20 Biotechnology Enterprises in Shenzhen (2019)".

In 2019

Lu Xianping, the Chairman of Chipscreen Biosciences, was appointed as a consultant of the Pingshan District Government.

In 2019

Lu Xianping, the Chairman of Chipscreen Biosciences, was appointed as an expert advisor of the Drug Production Qualified Person Committee of Guangdong Pharmaceutical Association.

In 2019

Chipscreen Biosciences was invited to participate in “the 40-Year Reform and Opening-up Exhibition” at Shenzhen Museum, and the tangible achievements of our anti-tumor innovative drug Chidamide was included in the collections of the museum.

2018

May 2018

The "Chemical innovative drug engineering technology research center" of CHIPSCREEN BIOSCIENCES was named as the Provincial engineering technology research center.

May 2018

Dr. Lu Xianping, Chairman of CHIPSCREEN BIOSCIENCES, won the "2017 China pharmaceutical development award for outstanding achievement award for innovative drugs".

January 2018

CHIPSCREEN BIOSCIENCES won the recognition of "caring enterprise" of the 2017 let love go home project.

2017

December 2017

Chidamide won the 19th China patent gold award.

June 2017

Dr. Lu Xianping, President of CHIPSCREEN BIOSCIENCES, was elected as the "2016 figure of Scientific Chinese".

March 2017

Chidamide won the most clinically valuable innovative drug of the 2016 China's innovative brand of medicine.

2016

December 2016

CHIPSCREEN BIOSCIENCES won the national titles of "high-tech enterprise" and "Shenzhen high-tech enterprise".

December 2016

CHIPSCREEN BIOSCIENCES was named as China's top 10 most potential innovative pharmaceutical enterprises by Sina Medicine.

October 2016

Dr. Lu Xianping, President of CHIPSCREEN BIOSCIENCES, won the first prize for outstanding theoretical achievements in China for his paper "making genuine original Chinese medicine."

June 2016

CHIPSCREEN BIOSCIENCES was selected as "globalization Shenzhen 100", the top 10 of new sharp globalization companies.

March 2016

Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, won "the most influential innovator" in China's medical innovation in 2015.

2015

September 2015

Dr. Lu Xianping, President of CHIPSCREEN BIOSCIENCES, was awarded the first Pacific life science achievement award during the 11th annual meeting of the Sino-American Biotechnology and Pharmaceutical Association (SABPA)

Dr. Lu Xianping, President of CHIPSCREEN BIOSCIENCES, was selected as the Forbes 2015 Sino-American innovator.

2014

September 2014

CHIPSCREEN BIOSCIENCES won the BayHelix and BioCentury “Award for R&D Achievement of the Year 2014”.

2013

December 2013

CHIPSCREEN BIOSCIENCES won first prize of the national science and technology progress award.

November 2013

Chidamide won the excellent product award during the 15th China international hi-tech achievement fair.

November 2013

Targeted anti-tumor innovative drug - the new epigenetic inhibitor "Chidamide" was selected for the national 863 program major achievements patrol exhibition.

2011

March 2011

"Innovative anti-tumor drugs - research and development of Chidamide" was selected during the "11th five-year plan" national major scientific and technological achievements exhibition.

2009

December 2009

CHIPSCREEN BIOSCIENCES received "special contribution award" from the China food and drug administration pharmaceutical examination center.

April 2009

CHIPSCREEN BIOSCIENCES was selected as a Shenzhen intellectual property advantage enterprise.

2008

November 2008

CHIPSCREEN BIOSCIENCES was awarded "the most valuable partner" by Roche China research and development center.

October 2008

CHIPSCREEN BIOSCIENCES won the title of Deloitte 2008 China's top 50 of hi-tech and high growth.

June 2008

CHIPSCREEN BIOSCIENCES was selected as the leading enterprise in Shenzhen's independent innovation industry.

May 2008

CHIPSCREEN BIOSCIENCES won the 2007 Shenzhen science and technology innovation award.

2005

December 2005

"Chemical innovative drug engineering technology center" of CHIPSCREEN BIOSCIENCES was named the municipal engineering center

2003

January 2003

CHIPSCREEN BIOSCIENCES was awarded as the "top 10 high-tech start-up enterprises in Shenzhen in 2002 - the most technologically innovative enterprise"

2002

August 2002

CHIPSCREEN BIOSCIENCES was selected as "the 10 most noteworthy companies" in Asia during the Asia Pacific Life Science and Technology Summit